Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

66.01
BATS BZX Real-Time Price
As of 12:27pm ET
 -0.16 / -0.24%
Today’s Change
45.45
Today|||52-Week Range
68.12
+11.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$107.8B

Company Description

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.

Contact Information

AbbVie, Inc.
1 North Waukegan Road
North Chicago Illinois 60064-6400
P:(847) 932-7900
Investor Relations:
(847) 935-2211

Employees

Shareholders

Mutual fund holders35.24%
Other institutional34.06%
Individual stakeholders0.09%

Top Executives

Richard A. GonzalezChairman & Chief Executive Officer
Azita Saleki-GerhardtSenior Vice President-Operations
William J. ChaseChief Financial Officer & Executive Vice President
Michael E. SeverinoChief Scientific Officer & Executive VP
Karen HaleVP, Chief Compliance & Ethics Officer